1. Just Say No…to the Nocebo Effect
- Author
-
Raymond K. Cross and Leah Rossmann
- Subjects
medicine.medical_specialty ,Drug Substitution ,business.industry ,Gastroenterology ,Biosimilar ,medicine.disease ,Inflammatory bowel disease ,Infliximab ,United States ,Nocebo Effect ,Humans ,Immunology and Allergy ,Medicine ,business ,Intensive care medicine ,Biosimilar Pharmaceuticals - Abstract
Biosimilars are highly similar products of an innovator biologic used to decrease costs. The nocebo effect is an increase in symptoms resulting from a patient’s negative perceptions about a biosimilar. Multistep notification, organized transition, and opt-out ability constitute a framework for switching patients from a reference product to a biosimilar.
- Published
- 2020
- Full Text
- View/download PDF